Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Harbor Advisors LLC

Harbor Advisors LLC boosted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 50.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 3,000 shares of the medical research company’s stock after acquiring an additional 1,000 shares during the period. Harbor Advisors LLC’s holdings in Thermo Fisher Scientific were worth $1,592,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TMO. International Assets Investment Management LLC grew its position in Thermo Fisher Scientific by 43.5% during the third quarter. International Assets Investment Management LLC now owns 1,626 shares of the medical research company’s stock valued at $810,000 after buying an additional 493 shares during the period. Arkadios Wealth Advisors lifted its holdings in Thermo Fisher Scientific by 33.3% during the third quarter. Arkadios Wealth Advisors now owns 896 shares of the medical research company’s stock valued at $454,000 after purchasing an additional 224 shares in the last quarter. Wedge Capital Management L L P NC lifted its holdings in Thermo Fisher Scientific by 8.3% during the third quarter. Wedge Capital Management L L P NC now owns 740 shares of the medical research company’s stock valued at $375,000 after purchasing an additional 57 shares in the last quarter. Summit Global Investments lifted its holdings in Thermo Fisher Scientific by 27.8% during the third quarter. Summit Global Investments now owns 1,392 shares of the medical research company’s stock valued at $704,000 after purchasing an additional 303 shares in the last quarter. Finally, Naples Global Advisors LLC lifted its holdings in Thermo Fisher Scientific by 37.3% during the third quarter. Naples Global Advisors LLC now owns 755 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 205 shares in the last quarter. Institutional investors and hedge funds own 89.23% of the company’s stock.

Insider Activity at Thermo Fisher Scientific

In related news, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $555.63, for a total value of $5,556,300.00. Following the completion of the transaction, the chief executive officer now owns 49,155 shares in the company, valued at $27,311,992.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Michael A. Boxer sold 14,566 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $562.00, for a total transaction of $8,186,092.00. Following the completion of the sale, the senior vice president now owns 12,901 shares in the company, valued at approximately $7,250,362. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $555.63, for a total transaction of $5,556,300.00. Following the sale, the chief executive officer now owns 49,155 shares of the company’s stock, valued at approximately $27,311,992.65. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,277 shares of company stock worth $28,513,384. Corporate insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on TMO. Royal Bank of Canada increased their price objective on shares of Thermo Fisher Scientific from $592.00 to $642.00 and gave the company an “outperform” rating in a report on Thursday, February 1st. Evercore ISI raised their price target on shares of Thermo Fisher Scientific from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Sanford C. Bernstein reissued a “market perform” rating on shares of Thermo Fisher Scientific in a research note on Monday, January 8th. Raymond James raised their price target on shares of Thermo Fisher Scientific from $515.00 to $605.00 and gave the stock an “outperform” rating in a research note on Thursday, February 1st. Finally, HSBC raised their price target on shares of Thermo Fisher Scientific from $630.00 to $660.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $604.69.

Thermo Fisher Scientific Trading Up 4.8 %

Shares of TMO traded up $26.21 during trading on Tuesday, reaching $574.59. 2,542,529 shares of the company traded hands, compared to its average volume of 1,562,245. Thermo Fisher Scientific Inc. has a twelve month low of $415.60 and a twelve month high of $603.82. The stock has a market cap of $219.33 billion, a PE ratio of 37.19, a price-to-earnings-growth ratio of 2.30 and a beta of 0.80. The stock has a 50-day simple moving average of $571.30 and a 200-day simple moving average of $528.18. The company has a quick ratio of 1.39, a current ratio of 1.75 and a debt-to-equity ratio of 0.67.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, January 31st. The medical research company reported $5.67 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $0.03. The firm had revenue of $10.89 billion during the quarter, compared to analysts’ expectations of $10.73 billion. Thermo Fisher Scientific had a net margin of 13.99% and a return on equity of 18.78%. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.40 earnings per share. On average, analysts anticipate that Thermo Fisher Scientific Inc. will post 21.51 earnings per share for the current year.

Thermo Fisher Scientific Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 15th were issued a $0.39 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.27%. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.35. Thermo Fisher Scientific’s payout ratio is 10.10%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.